Neoadjuvant therapy for resectable pancreatic ductal adenocarcinoma: The need for patient-centered research

Pancreatic ductal adenocarcinoma is an aggressive cancer with high recurrence rates following surgical resection. While adjuvant chemotherapy improves survival, a significant proportion of patients are unable to initiate or complete all intended therapy following pancreatectomy due to postoperative...

Full description

Saved in:
Bibliographic Details
Published in:World J Gastroenterol
Main Authors: Cloyd, Jordan M, Tsung, Allan, Hays, John, Wills, Celia E, Bridges, John FP
Format: Artigo
Language:Inglês
Published: Baishideng Publishing Group Inc 2020
Subjects:
Opinion Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7002907/
https://ncbi.nlm.nih.gov/pubmed/32063686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v26.i4.375
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items